Effect of Colchicine in patient presenting with non ST-elevation myocardial infarctio

Phase 3

Recruiting

• Conditions: on-ST elevation (NSTEMI) myocardial infarction.; Non-ST elevation (NSTEMI) myocardial infarction; I21.4

• Registration Number: IRCT20190601043780N1
• Lead Sponsor: Mashhad University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 October 2019

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 140

Inclusion Criteria

Patient presenting with non ST-elevation myocardial infarction

Exclusion Criteria

Patients under hemodialysis
GFR<30
thrombocytopenia
Severe Liver Failure (Liver enzyme > 3 times of normal)
dyspepsia or chronic diarrhea
Under treatment by corticosteroids or immunosuppressive medications
Under treatment by verapamil or diltiazem

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Hs-CRP. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of taking colchicine. Method of measurement: Biochemistry Lab (human hs crp elisa kit).

Secondary Outcome Measures

Name	Time	Method
Erythrocyte sedimentation rate (ESR). Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of taking colchicine. Method of measurement: Biochemistry Lab.;Mean platelet volume. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of taking colchicine. Method of measurement: hematology Lab.;LDL cholesterol. Timepoint: At the beginning of the study (before the intervention) and 4 weeks after the start of taking colchicine. Method of measurement: Biochemistry Lab.